| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/14/2004 | EP1379672A2 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc) |
| 01/14/2004 | EP1379671A2 Methods to culture circovirus |
| 01/14/2004 | EP1379669A2 Plant stress regulated genes |
| 01/14/2004 | EP1379668A2 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells |
| 01/14/2004 | EP1379667A2 Methods and compositions for highly efficient production of heterologous proteins in yeast |
| 01/14/2004 | EP1379664A1 Mhc tetramers |
| 01/14/2004 | EP1379660A2 Self-replicating rna molecule from hepatitis c virus |
| 01/14/2004 | EP1379659A2 Oryza sativa nuclear cap binding protein 80 |
| 01/14/2004 | EP1379658A2 Antimicrobial peptides and methods of use |
| 01/14/2004 | EP1379657A2 Disease-associated protein |
| 01/14/2004 | EP1379656A2 G-protein coupled receptor molecules and uses thereof |
| 01/14/2004 | EP1379655A2 Modified ciliary neurotrophic factor (cntf) with reduced immunogenicity |
| 01/14/2004 | EP1379654A2 Intracellular signaling molecules |
| 01/14/2004 | EP1379653A2 Testis protein, zsig86 |
| 01/14/2004 | EP1379652A2 Human nucleic acid molecules and polypeptides encoding a human ion channel expressed in spinal cord and brain |
| 01/14/2004 | EP1379651A2 Human genes and gene expression products isolated from human prostate |
| 01/14/2004 | EP1379650A2 Preferred segments of neural thread protein and methods of using the same |
| 01/14/2004 | EP1379649A2 Calcium binding proteins |
| 01/14/2004 | EP1379648A1 Full-length human cdnas encoding potentially secreted proteins |
| 01/14/2004 | EP1379647A2 Mammalian cytokines; receptors; related reagents and methods |
| 01/14/2004 | EP1379646A2 Engineered chimera of protein fragments and methods of use thereof |
| 01/14/2004 | EP1379644A2 Protein analysis by means of immobilized arrays of antigens or antibodies |
| 01/14/2004 | EP1379635A2 Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions |
| 01/14/2004 | EP1379630A2 Assays, methods and means relating to hypoxia inducible factor (hif) hydroxylase |
| 01/14/2004 | EP1379557A2 Use of cd25 binding molecules in steroid-resistant patients |
| 01/14/2004 | EP1379555A2 Modified interferon alpha with reduced immunogenicity |
| 01/14/2004 | EP1379554A2 Proteins, polynucleotides encoding them and methods of using the same |
| 01/14/2004 | EP1379553A2 Isolated human ras-like proteins, nucleic acid molecules encoding these human ras-like proteins, and uses thereof |
| 01/14/2004 | EP1379552A1 Toll-like receptor 5 ligands and methods of use |
| 01/14/2004 | EP1379551A2 Adp-ribosylating bacterial toxins |
| 01/14/2004 | EP1379550A2 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/14/2004 | EP1379549A2 Sequence of the photorhabdus luminescens strain tt01 genome and uses |
| 01/14/2004 | EP1379548A2 Novel rgs9 protein binding interactions and methods of use thereof |
| 01/14/2004 | EP1379544A1 Human lanosterol synthase, nucleic acid molecules encoding the same, and uses thereof |
| 01/14/2004 | EP1379543A1 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 01/14/2004 | EP1379540A2 Polynucleotides and polypeptides associated with the nf-kb pathway |
| 01/14/2004 | EP1379539A2 Methods and materials for making and using transgenic dicamba-degrading organisms |
| 01/14/2004 | EP1379538A1 Cea-expression inhibiting ribozymes and methods for the treatment of cancer based thereon |
| 01/14/2004 | EP1379535A2 Expression vectors able to elicit improved immune response and methods of using same |
| 01/14/2004 | EP1379283A2 Identification of target-specific folding sites in peptides and proteins |
| 01/14/2004 | EP1379282A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders |
| 01/14/2004 | EP1379276A1 Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonist |
| 01/14/2004 | EP1379275A2 Chronic obstructive pulmonary disease-related immunglobulin derived proteins, compositions, methods and uses |
| 01/14/2004 | EP1379272A2 Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies |
| 01/14/2004 | EP1379269A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease |
| 01/14/2004 | EP1379266A2 Modified annexin proteins and methods for preventing thrombosis |
| 01/14/2004 | EP1379265A2 Short bioactive peptides and methods for their use |
| 01/14/2004 | EP1379264A1 Human secreted proteins |
| 01/14/2004 | EP1379263A2 Mutated mhc molecules for use in immune suppression |
| 01/14/2004 | EP1379140A2 Production of pancreatic islet cells and delivery of insulin |
| 01/14/2004 | EP1379134A1 Recombinant adeno-assocaited virus-mediated gene transfer via retroductal infusion of virions |
| 01/14/2004 | EP1379132A2 Human secreted proteins |
| 01/14/2004 | EP0975761B1 Recombinant human beta interferon with enhanced solubility |
| 01/14/2004 | EP0942758B1 Compounds with improved inductive effect on cartilage and bones |
| 01/14/2004 | EP0832229B1 Cd40l mutein |
| 01/14/2004 | EP0816381B1 Polyethylene glycol modified hepatocyte growth factor (hgf) |
| 01/14/2004 | EP0725795B1 Single-chain forms of the glycoprotein hormone quartet |
| 01/14/2004 | EP0690991B2 Novel anticoagulant cofactor activity |
| 01/14/2004 | EP0636174B1 Hyaluronan receptor (rhamm = receptor for hyluronan mediated mobility) and hyaluronan binding peptides |
| 01/14/2004 | CN1468317A Use of multiple recombination sites with unique specificity in recombinational cloning |
| 01/14/2004 | CN1468312A Chimeric gfp-aequorin as bioluminescent ca<++> reporters at the single cell level |
| 01/14/2004 | CN1468310A Method for constructing cell strain of expression mutation type human tissue plasmin activator and preparation method of expressing protein |
| 01/14/2004 | CN1468306A Schizophrenia related gene and protein |
| 01/14/2004 | CN1468258A Glucagon-like peptide-1 analogs |
| 01/14/2004 | CN1468257A Trichosanthin mutant |
| 01/14/2004 | CN1468256A Purification of hbv antigens for use in vaccines |
| 01/14/2004 | CN1468255A Method for purifying recombinant proteins expressed as insoluble aggregates |
| 01/14/2004 | CN1467297A Technology for detecting foot and mouth disease virus antibody of sick livestock using recombination foot and mouth disease vaccine gene expressing protein |
| 01/14/2004 | CN1467224A Human serum albumins recombined merge protein having hyperplasia stimulation function to multiple cells |
| 01/14/2004 | CN1467222A Human interleukin-17 receptor sampling molecule fusion protein and coding gene and expression cell line |
| 01/14/2004 | CN1467221A Preparation and application of tubercle bacillus CFP-10, ESAT-6 and CD40L fusion bacterin |
| 01/14/2004 | CN1466996A Human SARS coronary virus receptor inhibitor |
| 01/14/2004 | CN1134666C Method and reagent used for detecting virus of hepatitis C |
| 01/14/2004 | CN1134542C Transgenic plants expressing DNA constructs containing plurality of genes to impart virus resistance |
| 01/14/2004 | CN1134539C Thrombopoietin |
| 01/14/2004 | CN1134452C Novel vitamin D receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 01/14/2004 | CN1134451C Inhibitor of collagen-stimulated platelet aggregation |
| 01/14/2004 | CN1134266C Methods for inducing T cell tolerance to tissue or organ graft |
| 01/13/2004 | US6677506 DNA coding for a Mg2+/H+ or Zn2+/H+ exchanger and transgenic plants expressing same |
| 01/13/2004 | US6677505 Promoter inductible in plants, sequence incorporating same and resulting product |
| 01/13/2004 | US6677504 Drought resistant and disease resistant plants; for use in the generation of agricultural products |
| 01/13/2004 | US6677503 Sunflower anti-pathogene proteins and genes and their uses |
| 01/13/2004 | US6677502 Plant metabolism genes |
| 01/13/2004 | US6677501 P2X7 receptor-deficient mice and uses thereof |
| 01/13/2004 | US6677500 Ungulates expressing exogenous IGF-I in their milk |
| 01/13/2004 | US6677444 Isolated dna encoding melanoma tumor-associated antigen |
| 01/13/2004 | US6677443 Isolated nucleic acid encoding lepidopteran octopamine/ tyramine transporter having sodium-dependent transport activity which has affinity for dopamine and which is inhibited by octopamine and tyramine |
| 01/13/2004 | US6677439 Methods for isolating T. pallidum rare outer membrane proteins |
| 01/13/2004 | US6677434 Isolated mammalian nucleic acid molecule encoding a receptor protein tyrosine kinase expressed in primitive hematopcietic cells and not expressed in mature hematopoietic cells |
| 01/13/2004 | US6677433 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins |
| 01/13/2004 | US6677432 Osteogenic protein-1 mutant having at least one amino acid residue substitution, and having improved in vitro refolding properties in ph range of about 6.0-9.0 |
| 01/13/2004 | US6677430 Polypeptides linked to labels used as detectors or kits for monitoring or analyzing biological receptors |
| 01/13/2004 | US6677428 Cdna with nucleotide sequence 1 and protein with amino acid sequence 2 |
| 01/13/2004 | US6677370 Stabilizing microtubules and preventing depolymerization; antiproliferative, anticarcinogenic and antiinflammatory agents; autoimmune diseases |
| 01/13/2004 | US6677312 Methods for restoring wild-type p53 gene function |
| 01/13/2004 | US6677307 TGF-α polypeptides, functional fragments and methods of use therefor |
| 01/13/2004 | US6677306 Amelogenin peptides; genetic engineering |
| 01/13/2004 | US6677305 Insulin-like growth factor agonist molecules |
| 01/13/2004 | US6677301 Epithelial cell proliferation stimulants; wound healing agents |
| 01/13/2004 | US6677299 Method to increase cerebral blood flow in amyloid angiopathy |